PPIs (proton pump inhibitors) reduce stomach acid and can help people whose nighttime heartburn or acid reflux disrupts sleep. They are not an established treatment for sleep apnea, which happens when breathing repeatedly stops or becomes shallow during sleep. A few small studies suggest possible benefit in some people who have both conditions, but the evidence is too limited to rely on PPIs to control sleep apnea.
What do PPIs treat, and how are they related to sleep?
Proton pump inhibitors, commonly called PPIs, are medicines that reduce the amount of acid produced by the stomach. Examples include omeprazole, esomeprazole, lansoprazole, and pantoprazole. They are commonly used to treat gastroesophageal reflux disease (GERD), a condition in which stomach contents flow back into the esophagus and cause repeated symptoms or complications.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), PPIs can relieve GERD symptoms and help heal the lining of the esophagus in many people. When acid reflux causes nighttime heartburn or discomfort, treating it may make sleep less interrupted. This benefit relates to reflux symptoms, however, and does not establish that PPIs treat the breathing problems associated with sleep apnea.
Obstructive sleep apnea (OSA) is different. It occurs when the upper airway repeatedly narrows or becomes blocked during sleep, interrupting normal breathing. These interruptions can cause snoring, gasping, repeated awakenings, and daytime tiredness. Reducing stomach acid does not directly keep the upper airway open, which is why a medicine that helps reflux cannot automatically be expected to control OSA.
What does research say about PPIs and sleep apnea?
The direct evidence is limited and inconsistent. A 2016 systematic review and meta-analysis available through the U.S. National Library of Medicine examined research on PPI treatment in people with both GERD and OSA. It included two randomized controlled trials and four prospective cohort studies. Some studies reported improvements in sleepiness or other sleep-related measures, but the results for breathing interruptions were inconsistent.
In that review, several studies found no significant improvement in the apnea-hypopnea index (AHI), a measure of how often breathing stops or becomes shallow during sleep. Other studies reported reductions in apnea-related measures. The authors concluded that the available evidence was insufficient to establish whether PPIs reliably improve OSA. They noted that PPIs may improve sleep quality when reflux is also present, even without a clear effect on the underlying breathing problem.
A separate systematic review and meta-analysis published in 2023 in the Journal of Gastroenterology and Hepatology, available through PubMed, examined the relationship between OSA and GERD. Across six studies involving 2,950 participants, the researchers found an association between the two conditions. However, among people with OSA, the presence of GERD was not associated with statistically significant differences in AHI, oxygen desaturation, sleep efficiency, or daytime sleepiness. These findings do not support assuming that treating reflux will reduce sleep apnea.
Overall, PPIs may be useful for people who have both reflux and sleep apnea, but their role is limited to managing reflux unless stronger evidence establishes another benefit. More robust clinical trials would be needed to determine whether acid-suppressing treatment can meaningfully improve sleep apnea itself.
Can PPIs improve sleep if you also have sleep apnea?
Yes, sleep may improve in some people when nighttime reflux is a contributing problem. Acid reflux can cause burning discomfort, an unpleasant taste in the mouth, or repeated awakenings. If these symptoms are interrupting sleep, effective GERD treatment may reduce that disruption. A person may therefore feel more rested without experiencing any meaningful change in the frequency of breathing interruptions during sleep.
This distinction matters when judging whether a treatment is working. Better sleep or less daytime tiredness does not necessarily mean that sleep apnea has improved. Reflux symptoms and breathing interruptions are different problems and may need separate assessment. If sleep remains unrefreshing, loud snoring or gasping continues, or daytime sleepiness persists despite improved heartburn, a healthcare professional can determine whether further evaluation is needed.
Which treatments actually target sleep apnea?
Sleep apnea treatment aims to prevent the airway from narrowing or becoming blocked during sleep. The appropriate option depends on the type of sleep apnea, its clinical impact, other health conditions, and individual needs.
The National Heart, Lung, and Blood Institute (NHLBI) identifies positive airway pressure (PAP) therapy as the most common treatment for sleep apnea. Continuous positive airway pressure (CPAP) delivers air through a mask to help keep the airway open during sleep. Other options may include custom-fitted oral appliances, changes in sleep position, lifestyle measures, or selected surgical procedures, depending on the person's circumstances.
The American Academy of Sleep Medicine's clinical practice guideline recommends PAP therapy for adults with OSA in appropriate clinical circumstances. Treatment decisions should be based on an established diagnosis, generally using a home sleep apnea test or an overnight sleep study when indicated. PPIs are not a substitute for these treatments and should not be used as the sole treatment for suspected or confirmed sleep apnea.
What should you do if you have both acid reflux and sleep apnea?
If you experience nighttime heartburn alongside symptoms such as loud snoring, witnessed pauses in breathing, gasping during sleep, or persistent daytime sleepiness, mention both sets of symptoms to your healthcare professional. The timing of symptoms, medical history, examination findings, and sleep-study results, when needed, help guide the next steps.
If a PPI has been prescribed for GERD, take it according to the prescribed instructions. Do not start one specifically to treat sleep apnea, increase the dose because sleep remains poor, or stop a prescribed medicine without discussing the decision with a healthcare professional. Long-term treatment should be reviewed periodically to confirm that the medication remains appropriate for its intended purpose.
For reflux-related discomfort at night, practical measures may also help. The NIDDK recommends options such as raising the head of the bed and adjusting eating habits to reduce reflux symptoms. These measures may support better sleep when reflux is the problem, but they do not replace treatment directed at sleep apnea.
Most of the evidence on PPIs and sleep apnea discussed here concerns adults. Children with persistent snoring or pauses in breathing need age-appropriate medical assessment; the adult research on PPIs should not be used to guide sleep apnea treatment in children.
The bottom line: Are PPIs worth taking for sleep apnea?
PPIs can be worthwhile when acid reflux is causing symptoms that interrupt sleep. However, current evidence does not establish them as an effective treatment for obstructive sleep apnea or show that they reliably reduce breathing interruptions. If both conditions are present, reflux should be managed for its own health effects, while sleep apnea should be assessed and treated with appropriate sleep-focused care.